Meningococcal A conjugate vaccine coverage in the meningitis belt of Africa from 2010 to 2021: a modelling studyResearch in context

Summary: Background: As of the end of 2021, twenty-four countries in the African meningitis belt have rolled out mass campaigns of MenAfriVac®, a meningococcal A conjugate vaccine (MACV) first introduced in 2010. Twelve have completed introduction of MACV into routine immunisation (RI) schedules. A...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Rose G. Bender, Jasmine Shen, Aleksandr Aravkin, André Arsène Bita Fouda, Ado M. Bwaka, Natalie C. Galles, Emily Haeuser, Simon I. Hay, Anderson Latt, Jason M. Mwenda, Emma L.B. Rogowski, Alyssa N. Sbarra, Reed J.D. Sorensen, Avina Vongpradith, Claire Wright, Peng Zheng, Jonathan F. Mosser, Hmwe H. Kyu
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Elsevier 2023-02-01
Ráidu:	EClinicalMedicine
Fáttát:	Meningitis MenAfriVac Meningococcal vaccination Meningitis belt Vaccination coverage Meningococcal disease
Liŋkkat:	http://www.sciencedirect.com/science/article/pii/S2589537022005260
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!